Four Decades for Justice
Jesse M. Weiss has a broad litigation practice, with a particular focus on antitrust, including antitrust counseling, regulatory work and antitrust litigation.
Recent representative matters include:
Representation of Tesla in consolidated putative class action antitrust litigation alleging Tesla has monopolized access to parts and services needed to repair its vehicles, and that the company’s actions have resulted in delays and supracompetitive pricing for Tesla vehicle maintenance.
Representation of Amgen in successfully defending against an FTC challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close.
Representation of Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
Representation of Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
Mr. Weiss was a contributing author of the Mergers and Acquisitions chapter of the American Bar Association’s eighth (2017) and ninth (2022) editions of Antitrust Law Developments and the Mergers and Acquisitions chapter of the Annual Review of Antitrust Law Developments from 2018 through 2022.
Mr. Weiss was born in New York City. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. He joined Cravath in 2008 and was elected of counsel in 2021. Mr. Weiss is admitted to practice before the U.S. District Courts for the Eastern District of New York and the Southern District of New York.
Recent representative matters include:
Representation of Tesla in consolidated putative class action antitrust litigation alleging Tesla has monopolized access to parts and services needed to repair its vehicles, and that the company’s actions have resulted in delays and supracompetitive pricing for Tesla vehicle maintenance.
Representation of Amgen in successfully defending against an FTC challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close.
Representation of Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
Representation of Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
Mr. Weiss was a contributing author of the Mergers and Acquisitions chapter of the American Bar Association’s eighth (2017) and ninth (2022) editions of Antitrust Law Developments and the Mergers and Acquisitions chapter of the Annual Review of Antitrust Law Developments from 2018 through 2022.
Mr. Weiss was born in New York City. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. He joined Cravath in 2008 and was elected of counsel in 2021. Mr. Weiss is admitted to practice before the U.S. District Courts for the Eastern District of New York and the Southern District of New York.
American Bar Association
New York City Bar Association
Deals & Cases
October 02, 2023
On September 21, 2023, Cisco, a leading global technology company, and Splunk, a cybersecurity and observability leader, announced a definitive agreement under which Cisco intends to acquire Splunk for $157 per share in cash, representing approximately $28 billion in equity value. Cravath is representing Cisco on regulatory matters in connection with the transaction.
Deals & Cases
September 19, 2023
On September 19, 2023, affiliates of private investment firm Lindsay Goldberg, in partnership with the company’s management, announced the completion of an investment in The Kleinfelder Group, a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
September 18, 2023
On September 18, 2023, OMERS Private Equity announced the signing of a definitive agreement to acquire a majority stake in Knight Commercial, a leading provider of commercial restoration services. Cravath is representing OMERS Private Equity in connection with the transaction.
Deals & Cases
September 12, 2023
On September 12, 2023, the Boards of WestRock and Smurfit Kappa announced the signing of a definitive transaction agreement to create Smurfit WestRock, a global leader in sustainable packaging. Together, Smurfit Kappa and WestRock generated combined last twelve months’ adjusted annual revenue of approximately $34 billion as of June 30, 2023. Cravath is representing WestRock in connection with the transaction.
Deals & Cases
September 11, 2023
Cravath represented Amgen, one of the world’s largest biopharmaceutical companies, in successfully defending against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that The Wall Street Journal described as “a rare instance” of the FTC “throwing in the towel on litigation.”
Accolades
September 08, 2023
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott, Timothy G. Cameron and Daniel K. Zach and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Firm News
January 18, 2022
On December 21, 2021, Cravath elected Jesse M. Weiss and Michael J. Zaken as of counsel of the Firm.
Jesse M. Weiss has a broad litigation practice, with a particular focus on antitrust, including antitrust counseling, regulatory work and antitrust litigation.
Recent representative matters include:
Representation of Tesla in consolidated putative class action antitrust litigation alleging Tesla has monopolized access to parts and services needed to repair its vehicles, and that the company’s actions have resulted in delays and supracompetitive pricing for Tesla vehicle maintenance.
Representation of Amgen in successfully defending against an FTC challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close.
Representation of Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
Representation of Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
Mr. Weiss was a contributing author of the Mergers and Acquisitions chapter of the American Bar Association’s eighth (2017) and ninth (2022) editions of Antitrust Law Developments and the Mergers and Acquisitions chapter of the Annual Review of Antitrust Law Developments from 2018 through 2022.
Mr. Weiss was born in New York City. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. He joined Cravath in 2008 and was elected of counsel in 2021. Mr. Weiss is admitted to practice before the U.S. District Courts for the Eastern District of New York and the Southern District of New York.
Recent representative matters include:
Representation of Tesla in consolidated putative class action antitrust litigation alleging Tesla has monopolized access to parts and services needed to repair its vehicles, and that the company’s actions have resulted in delays and supracompetitive pricing for Tesla vehicle maintenance.
Representation of Amgen in successfully defending against an FTC challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics, the largest in Amgen’s history. In September 2023, Amgen secured a consent order that ended all litigation and cleared the path for the deal to close.
Representation of Altra Industrial Motion Corp. on antitrust issues in connection with its $5 billion acquisition by Regal Rexnord Corporation.
Representation of Atlas Air Worldwide Holdings on antitrust issues in connection with its $5.2 billion acquisition by an investor group led by funds managed by affiliates of Apollo Global Management.
Mr. Weiss was a contributing author of the Mergers and Acquisitions chapter of the American Bar Association’s eighth (2017) and ninth (2022) editions of Antitrust Law Developments and the Mergers and Acquisitions chapter of the Annual Review of Antitrust Law Developments from 2018 through 2022.
Mr. Weiss was born in New York City. He received a B.A. from the University of Maryland in 2003 and a J.D. magna cum laude from Georgetown University Law Center in 2008. He joined Cravath in 2008 and was elected of counsel in 2021. Mr. Weiss is admitted to practice before the U.S. District Courts for the Eastern District of New York and the Southern District of New York.
American Bar Association
New York City Bar Association
Deals & Cases
October 02, 2023
On September 21, 2023, Cisco, a leading global technology company, and Splunk, a cybersecurity and observability leader, announced a definitive agreement under which Cisco intends to acquire Splunk for $157 per share in cash, representing approximately $28 billion in equity value. Cravath is representing Cisco on regulatory matters in connection with the transaction.
Deals & Cases
September 19, 2023
On September 19, 2023, affiliates of private investment firm Lindsay Goldberg, in partnership with the company’s management, announced the completion of an investment in The Kleinfelder Group, a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
September 18, 2023
On September 18, 2023, OMERS Private Equity announced the signing of a definitive agreement to acquire a majority stake in Knight Commercial, a leading provider of commercial restoration services. Cravath is representing OMERS Private Equity in connection with the transaction.
Deals & Cases
September 12, 2023
On September 12, 2023, the Boards of WestRock and Smurfit Kappa announced the signing of a definitive transaction agreement to create Smurfit WestRock, a global leader in sustainable packaging. Together, Smurfit Kappa and WestRock generated combined last twelve months’ adjusted annual revenue of approximately $34 billion as of June 30, 2023. Cravath is representing WestRock in connection with the transaction.
Deals & Cases
September 11, 2023
Cravath represented Amgen, one of the world’s largest biopharmaceutical companies, in successfully defending against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that The Wall Street Journal described as “a rare instance” of the FTC “throwing in the towel on litigation.”
Accolades
September 08, 2023
On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott, Timothy G. Cameron and Daniel K. Zach and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.
Firm News
January 18, 2022
On December 21, 2021, Cravath elected Jesse M. Weiss and Michael J. Zaken as of counsel of the Firm.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. © 2023 Cravath, Swaine & Moore LLP.